Association of adipocytokines with lipid and glycemic profiles in women with normal weight obesity

BMC Endocrine Disorders

Table 2 Biochemical characteristics of participants in NWO and control groups

Variables	NWO (case) group (n = 40)	NWNO (control) group (n = 30)	P-value
FBS^a (mg/dl)	82.71 ± 8.16	84.44 ± 7.33	0.45
Insulin^a (μIU/ml)	9.02 ± 4.75	6.24 ± 2.51	0.009
HOMA-IR^a	33.77 ± 20.71	23.48 ± 10.03	0.02
TC^a (mg/dl)	174.00 ± 29.35	173.84 ± 21.56	0.94
TG^a (mg/dl)	87.07 ± 28.28	82.64 ± 27.18	0.53
HDL^a (mg/dl)	59.02 ± 13.70	61.04 ± 9.10	0.52
LDL^a (mg/dl)	90.89 ± 18.08	89/04 ± 17.23	0.68
Leptin^b (pg/ml)	16.45 (11.70–20.00)	9.60 (6.50–13.40)	< 0.001
Vaspin^b (pg/ml)	0.16 (0.04–0.20)	0.05 (0.01–0.90)	0.57

NWO Normal weight obesity, FBS Fasting blood sugar, HOMA-IR Homeostasis model assessment of insulin resistance, TC Total cholesterol, TG Triglyceride, HDL High-density lipoprotein, LDL Low-density lipoprotein, IQR Interquartile range
^aData expressed as mean ± SD and compared between two groups using t-test
^bData expressed as median (IQR) and compared between two groups using Mann-Whitney
P < 0.05 is statistically significant

ISSN: 1472-6823